Patent 10293046 was granted and assigned to Intellipharmaceutics International on May, 2019 by the United States Patent and Trademark Office.
Drug delivery formulations, uses thereof and methods of making same are provided in order to reduce the potential for abuse, misuse or improper administration of an addictive substance or any active substance and to prevent, reduce, inhibit, or delay purposeful or accidental overdose of an active substance by ingesting too many dosage forms at once, for example.